Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States
Sumedha Gupta, Jonathan Cantor, Kosali Simon, et al.
Health Affairs (2021) Vol. 40, Iss. 9, pp. 1465-1472
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Monetary incentives increase COVID-19 vaccinations
Pol Campos‐Mercade, Armando N. Meier, Florian Schneider, et al.
Science (2021) Vol. 374, Iss. 6569, pp. 879-882
Open Access | Times Cited: 265
Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021
Molly Steele, Alexia Couture, Carrie Reed, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2220385-e2220385
Open Access | Times Cited: 105
COVID-19 vaccination mandates and vaccine uptake
Alexander Karaivanov, Dongwoo Kim, Shih En Lu, et al.
Nature Human Behaviour (2022) Vol. 6, Iss. 12, pp. 1615-1624
Open Access | Times Cited: 101
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis
Thomas J. Bollyky, Emma Castro, Aleksandr Y. Aravkin, et al.
The Lancet (2023) Vol. 401, Iss. 10385, pp. 1341-1360
Open Access | Times Cited: 101
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort
Robert W Aldridge, Alexei Yavlinsky, Vincent Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis
Giovanni Corona, Walter Vena, Alessandro Pizzocaro, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 12, pp. 2207-2219
Open Access | Times Cited: 53
COVID-19 Vaccine Hesitancy and Experiences of Discrimination Among Black Adults
Don E. Willis, Jennifer A. Andersen, Brooke E. E. Montgomery, et al.
Journal of Racial and Ethnic Health Disparities (2022) Vol. 10, Iss. 3, pp. 1025-1034
Open Access | Times Cited: 50
The Association Between COVID-19 Mortality And The County-Level Partisan Divide In The United States
Neil Sehgal, Dahai Yue, Elle Pope, et al.
Health Affairs (2022) Vol. 41, Iss. 6, pp. 853-863
Closed Access | Times Cited: 43
One Year of COVID-19 Vaccine Misinformation on Twitter: Longitudinal Study
Francesco Pierri, Matthew DeVerna, Kai‐Cheng Yang, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e42227-e42227
Open Access | Times Cited: 32
Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review
Joht Singh Chandan, Kirsty Brown, Nikita Simms-Williams, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3477-3477
Open Access | Times Cited: 30
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
Suzana Margareth Lobo, Gaëtan Plantefève, Girish B. Nair, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102383-102383
Open Access | Times Cited: 10
Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy
Eleonor Zavala, Carleigh Krubiner, Elana Jaffe, et al.
BMJ Global Health (2022) Vol. 7, Iss. 2, pp. e007730-e007730
Open Access | Times Cited: 36
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective
Jasmine R Marcelin, Audrey Pettifor, Holly Janes, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 33
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
Analysis of SARS-CoV-2 genome evolutionary patterns
Shubhangi Gupta, Deepanshu Gupta, Sonika Bhatnagar
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 6
Predictors of COVID-19 vaccine recommendation practices among healthcare providers in the US.
Alice R. Richman, Abby Schwartz, Essie Torres, et al.
Patient Education and Counseling (2025) Vol. 134, pp. 108687-108687
Closed Access
Perspectives of medical sciences students regarding COVID-19 vaccination: a cross-sectional study
Maryam Aghabarary, Mahsa Khedmatizare, Roohangiz Norouzinia
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 605-617
Open Access | Times Cited: 26
Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
Eustache Paramithiotis, Scott Sugden, Eszter Papp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Return on Investment of the COVID-19 Vaccination Campaign in New York City
Pratha Sah, Thomas N. Vilches, Seyed M. Moghadas, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2243127-e2243127
Open Access | Times Cited: 23
Pathogen evolution during vaccination campaigns
Troy Day, David Kennedy, Andrew F. Read, et al.
PLoS Biology (2022) Vol. 20, Iss. 9, pp. e3001804-e3001804
Open Access | Times Cited: 22
Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents
Chris A. Gentry, Phoi N Nguyen, Sharanjeet K. Thind, et al.
Journal of Infection (2023) Vol. 86, Iss. 3, pp. 248-255
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top